AbCellera to Present at Upcoming Investor Conferences in March

Group 1 - AbCellera will present at the 44th Annual TD Cowen Health Care Conference on March 5, 2024, at 11:50 a.m. Pacific Time [1] - The company will also present at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 20, 2024, at 8:15 a.m. Pacific Time [1] - Live audio webcasts of the presentations will be available on AbCellera's Investor Relations website, with replays accessible afterward [1] Group 2 - AbCellera is focused on advancing antibody discovery to deliver better medicines to patients more quickly [2] - The company integrates expert teams, technology, and data science to enhance the development of antibody-based medicines across various therapeutic areas [2] - AbCellera aims to provide a competitive advantage to innovative biotechs and leading pharmaceutical companies, enabling them to reduce costs and address complex drug development challenges [2]